Jae-Hoon Yoon
Vorstandsvorsitzender bei RP BIO INC.
Vermögen: 28 Mio $ am 30.04.2024
Profil
Jae-Hoon Yoon currently works at RP Bio, lnc., as Co-Chief Executive Officer & Director.
Mr. Yoon also formerly worked at Daewoong Pharmaceutical Co., Ltd., as Vice Chairman & Chief Executive Officer from 1992 to 2010, Daewoong International Corp., as Vice Chairman in 2011, Daewoong Co., Ltd., as Director in 2011, Daewoong Bio, Inc., as Director, R&P Korea Co., Ltd., as Director, and Daewoong Development Co., Ltd., as Director.
Mr. Yoon received his graduate degree from the University of Denver.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
RPBIO INC.
48,27% | 07.10.2022 | 4 183 480 ( 48,27% ) | 28 Mio $ | 30.04.2024 |
Aktive Positionen von Jae-Hoon Yoon
Unternehmen | Position | Beginn |
---|---|---|
RP BIO INC. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jae-Hoon Yoon
Unternehmen | Position | Ende |
---|---|---|
Daewoong Development Co., Ltd.
Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The private company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Direktor/Vorstandsmitglied | - |
Daewoong International Corp. | Direktor/Vorstandsmitglied | - |
R&P Korea Co., Ltd. | Direktor/Vorstandsmitglied | 05.07.2011 |
Daewoong Bio, Inc.
Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Direktor/Vorstandsmitglied | - |
DAEWOONG CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jae-Hoon Yoon
University of Denver | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
DAEWOONG CO., LTD. | Health Technology |
DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
RP BIO INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Daewoong Bio, Inc.
Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Commercial Services |
Daewoong International Corp. | |
R&P Korea Co., Ltd. | |
Daewoong Development Co., Ltd.
Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The private company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Finance |